
Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer.

Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer.


From petitioning national lawmakers to provide more funding for stomach cancer to holding survivor banquets in their backyards, volunteers at Debbie's Dream Foundation are dedicated to ending the disease.

Published: March 7th 2016 | Updated:

Published: March 23rd 2016 | Updated: